EpiBiome Obtains $6,000,000 Series A Financing

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    329 Oyster Point Blvd. 3rd Floor South San Francisco, CA 94080 USA
  • Company Description
    EpiBiome is a precision microbiome engineering company based in South San Francisco with the mission of developing effective and sustainable FDA-approved therapies to combat infectious disease in humans and in agriculture without the use of antibiotics.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds from the financing will be used to develop alternatives to small-molecule antibiotics.
  • M&A Terms
  • Venture Investor
    Matrix Capital Management
  • Venture Investor
    Alexandria Venture Investments
  • Venture Investor
    SV Tech Ventures
  • Venture Investor
    ChinaRock Capital Management
  • Venture Investor
    Illumina Accelerator Program

Trending on Xconomy